This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Nektar Therapeutics Inc
NKTR : NASDAQ : Health Care
$15.50 up0.29 | 1.90%
Today's Range: 15.12 - 15.63
Avg. Daily Volume: 1,557,400
11/30/15 - 10:54 AM ET

PEER GROUP: Pharmaceuticals

Ticker Company Name Recent
Net Sales
Net Income
NKTR NEKTAR THERAPEUTICS 15.64 2087.17 n/m 210.97 -0.63
IPXL IMPAX LABORATORIES INC 44.72 3153.39 120.86 709.59 25.46
MDCO MEDICINES CO 42.64 2961.09 n/m 480.66 -33.10
PBH PRESTIGE BRANDS HOLDINGS 53.06 2798.76 27.35 785.85 27.80
ITCI INTRA-CELLULAR THERAPIES INC 58.28 2507.38 n/m 0.13 -90.59
PCRX PACIRA PHARMACEUTICALS INC 64.93 2386.63 259.72 241.47 42.50
CEMP CEMPRA INC 32.81 1442.56 n/m 23.98 61.84
LCI LANNETT CO INC 39.29 1435.19 9.87 419.88 30.67
TXMD THERAPEUTICSMD INC 7.64 1358.39 n/m 18.77 37.70
DEPO DEPOMED INC 19.02 1150.35 40.47 426.17 80.29
RVNC REVANCE THERAPEUTICS INC 38.86 1090.49 n/m 0.30 -51.38
The peer group comparison is based on Major Pharmaceuticals companies of comparable size.

Price Earnings Comparison

NKTR Ind Avg S&P 500
n/m 28.45 22.01

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Real Money
Try it NOW

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums

Latest Stock Upgrades/Downgrades

Top Rated Stocks Top Rated Funds Top Rated ETFs